Carl Zeiss Meditec AG buy papaver
Summary
This prediction ended on 05.12.13 with a price of €24.69. The BUY prediction by papaver finished with a performance of 6.89%. papaver has 50% into this predictionCarl Zeiss Meditec AG is a German-based company that produces medical devices for ophthalmology and microsurgery. It operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment includes diagnostic and surgical equipment for the anterior and posterior segments of the eye. The Microsurgery segment offers products for neurosurgery, spinal and ENT surgeries, and dental applications. The company has a global reach and serves customers in more than 115 countries through its subsidiaries and distribution network. Carl Zeiss Meditec has been listed on the Frankfurt and TecDAX stock exchanges since 2007.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Carl Zeiss Meditec AG | 1.825% | 1.825% | -14.779% | -59.065% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
Comments by papaver for this prediction
In the thread Carl Zeiss Meditec AG diskutieren
Stabile Zahlen
Nach einem schwachen Jahresstart hat Carl Zeiss gute Q3 Zahlen genannt. Trotz eines scharfen Wettbewerbs erwartet dasUnternehmen einen Umsatz von 880 bis 910 Millionen Euro. Das wäre ein Zuwachs von zwei bis sechs Prozent.
Stopped prediction by papaver for Carl Zeiss Meditec AG
Carl Zeiss Meditec AG
30.08.11
21.12.11
21.12.11